Target intelligence / Profile preview

Gut-microbiota-brain-immune axis (GMBIA) (GMBIA)

Target
GMBIA
Molecular classification
G protein-coupled receptor, Short-chain fatty acid, Cytokine, Neurotransmitter, Histone deacetylase
01

Overview

The gut-microbiota-brain-immune axis is a complex, bidirectional communication network that integrates the metabolic activity of the intestinal microbiome with the host's central nervous and immune systems. Central to this axis are short-chain fatty acids (SCFAs), such as butyrate, acetate, and propionate, which are produced by microbial fermentation of non-digestible carbohydrates (Cryan & Dinan, 2012, Nat Rev Neurosci). These metabolites act as signaling molecules by binding to specific G protein-coupled receptors (e.g., FFAR2, FFAR3) and by inhibiting histone deacetylases, thereby influencing the production of host neurotransmitters like serotonin and the secretion of cytokines (Koh et al., 2016, Cell; Yano et al., 2015, Cell). By modulating the systemic inflammatory environment and signaling through the vagus nerve, the axis plays a critical role in maintaining neurological health and immune homeostasis (Smith et al., 2013, Science). Dysregulation of this network is strongly associated with neurodegenerative conditions like Parkinson’s disease and psychiatric disorders such as major depression (Sampson et al., 2016, Cell). Therapeutic strategies targeting this axis include the use of prebiotics, probiotics, and postbiotics to restore a healthy microbial balance and optimize SCFA-mediated signaling.

Other names
Microbiome-gut-brain axisGut-brain axisGut-immune-brain axisSCFA-mediated signaling pathwayMicrobiota-neuro-immune axis
02

Mechanism of action

The axis functions through the microbial fermentation of dietary fibers into short-chain fatty acids (SCFAs) like butyrate, acetate, and propionate, which act as ligands for G protein-coupled receptors (GPR41/FFAR3 and GPR43/FFAR2) and as inhibitors of histone deacetylases (HDACs) (Koh et al., 2016, Cell). This signaling triggers the release of neurotransmitters such as serotonin from enterochromaffin cells and modulates the systemic cytokine profile by inducing the differentiation of regulatory T cells (Tregs) and suppressing pro-inflammatory mediators like TNF-alpha and IL-6 (Smith et al., 2013, Science; Yano et al., 2015, Cell). These signals are transmitted to the central nervous system via the vagus nerve or systemic circulation, influencing neuroinflammation and behavior (Cryan & Dinan, 2012, Nat Rev Neurosci).

03

Biological functions

Signal transductionImmune responseNeuromodulationMetabolic regulationHomeostasis
04

Disease associations

Neurodegenerative diseaseInflammationMental health disorderMetabolic syndromeAutoimmune disease
05

Safety considerations

Risk of bacteremia in immunocompromised patients using probioticsGastrointestinal distress from prebiotic fiber overloadUnintended systemic immune activationHigh inter-individual variability in microbiome composition and response
06

Interacting drugs

Sodium butyrate

6 more in the full profile.

07

Biomarkers

Fecal short-chain fatty acid levelsMicrobial alpha diversityInterleukin-10 (IL-10)Tumor Necrosis Factor-alpha (TNF-alpha)Fecal calprotectinPlasma tryptophan levels

Beyond the preview

Go deeper on Gut-microbiota-brain-immune axis (GMBIA) (GMBIA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut-microbiota-brain-immune axis (GMBIA) (GMBIA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call